Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
J Diabetes. 2024 Jan;16(1):e13459. doi: 10.1111/1753-0407.13459. Epub 2023 Aug 16.
Diabesity is a term used to emphasize the dual epidemic and the combined detrimental effects of diabetes and obesity. We aimed to investigate the associations of diabesity with the incidence and resolution of nonalcoholic fatty liver disease (NAFLD).
This prospective cohort study included 5549 participants with a median follow-up of 4.3 years (2010-2015). Diabesity was defined as six categories by the combinations of glucose tolerance status (normal glucose tolerance [NGT], prediabetes, and diabetes) diagnosed by fasting and oral glucose tolerance test 2-h glucose and hemoglobin A1c and general or abdominal obesity status. We examined the odds ratios (ORs) for the incidence and resolution of NAFLD associated with diabesity categories, respectively.
For NAFLD incidence, compared with the diabesity category of NGT with nonobesity, the categories of either glucose intolerance or general obesity were associated with higher risks of NAFLD, of which the categories with obesity, regardless of glucose intolerance status, exhibited greater risks (ORs ranged from 3.19 to 4.49) than the categories of nonobesity. For NAFLD resolution, the categories of prediabetes or diabetes with obesity were associated with decreased likelihoods of a resolution of NAFLD (ORs ranged from 0.40 to 0.58). These association patterns were consistent across various definitions of diabesity by glucose tolerance status diagnosed by different combinations of glycemic parameters and general or abdominal obesity.
The diabesity association pattern with NAFLD incidence was mainly determined by obesity, while that with NAFLD resolution was driven by the combined phenotype of glucose intolerance and obesity.
糖尿病肥胖症是一个术语,用于强调糖尿病和肥胖症的双重流行及其联合的有害影响。我们旨在研究糖尿病肥胖症与非酒精性脂肪性肝病(NAFLD)的发病和缓解之间的关系。
本前瞻性队列研究纳入了 5549 名参与者,中位随访时间为 4.3 年(2010-2015 年)。糖尿病肥胖症通过空腹和口服葡萄糖耐量试验 2 小时血糖和糖化血红蛋白以及普通或腹部肥胖状态来诊断,根据葡萄糖耐量状态(正常糖耐量[NGT]、糖尿病前期和糖尿病)的组合将其分为 6 类。我们分别检查了与糖尿病肥胖症类别相关的 NAFLD 发病和缓解的比值比(OR)。
对于 NAFLD 的发病,与 NGT 且非肥胖的糖尿病肥胖症类别相比,葡萄糖不耐受或普通肥胖的类别与更高的 NAFLD 发病风险相关,其中肥胖类别的风险更高(OR 范围为 3.19 至 4.49),而无论葡萄糖耐量状态如何,肥胖类别的风险都高于非肥胖类别的风险。对于 NAFLD 的缓解,肥胖的糖尿病前期或糖尿病类别与 NAFLD 缓解的可能性降低相关(OR 范围为 0.40 至 0.58)。这些关联模式在通过不同血糖参数组合和普通或腹部肥胖诊断的葡萄糖耐量状态的不同糖尿病肥胖症定义中均具有一致性。
与 NAFLD 发病相关的糖尿病肥胖症关联模式主要由肥胖决定,而与 NAFLD 缓解相关的关联模式则由葡萄糖不耐受和肥胖的联合表型驱动。